Nathan Collins discusses how the SynFini automated chemistry platform is accelerating drug development and discovery. Learn more about SynFini at: www.sri.com/case-studies/synfini/
Nathan Collins talks about how the SynFini automated chemistry platform is accelerating drug development and discovery.
Read more from SRI
-
Robot teams that talk to humans
SRI scientists created a new AI-based approach to robotics that enables mobile robots to effectively communicate with each other — and with their human operators.
-
Avsr AI: Teaching robots autonomy and dexterity
An SRI spinout is leveraging SRI technology to increase the dexterity and flexibility of our future robotic collaborators.
-
Joe Sawa: Scaling breakthrough hydrogen separation to decarbonize industry
As the CEO of Membravo and former SRI entrepreneur-in-residence, Joe Sawa is harnessing a novel SRI-invented polymer membrane to feed the world’s need for pure hydrogen.